AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout

Pharmaceutical companies are hungry to make deals, and they’re making more than they have in years.

AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout